We are live on ! Find out more
CCC

Crescent Capital Consulting Portfolio holdings

AUM $607M
1-Year Est. Return 22.88%
This Fund
S&P 500
This Quarter Est. Return
-1.07%
1 Year Est. Return
+22.88%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$546M
AUM Growth
+$11.4M
Cap. Flow
+$36.1M
Cap. Flow %
6.61%
Top 10 Hldgs %
38.58%
Holding
625
New
124
Increased
56
Reduced
87
Closed
32
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DIA icon
26
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
$46.3B
$5.31M 0.97%
15,702
+838
+6% +$293K
VHT icon
27
Vanguard Health Care ETF
VHT
$18B
$5.18M 0.95%
20,964
+7,207
+52% +$1.85M
ESGV icon
28
Vanguard ESG US Stock ETF
ESGV
$13.5B
$5.16M 0.95%
64,489
-948
-1% -$78.1K
IJK icon
29
iShares S&P Mid-Cap 400 Growth ETF
IJK
$11B
$4.54M 0.83%
57,348
-1,528
-3% -$124K
IJT icon
30
iShares S&P Small-Cap 600 Growth ETF
IJT
$8.45B
$4.54M 0.83%
34,919
-1,206
-3% -$159K
IWP icon
31
iShares Russell Mid-Cap Growth ETF
IWP
$20.4B
$4.54M 0.83%
40,540
-3,920
-9% -$451K
IWO icon
32
iShares Russell 2000 Growth ETF
IWO
$14.8B
$4.43M 0.81%
15,086
-383
-2% -$115K
KO icon
33
Coca-Cola
KO
$371B
$4.21M 0.77%
80,398
LLY icon
34
Eli Lilly
LLY
$1T
$4.1M 0.75%
17,741
-82
-0.5% -$20.2K
DVYE icon
35
iShares Emerging Markets Dividend ETF
DVYE
$1.22B
$3.86M 0.71%
99,264
-1,754
-2% -$67.9K
PG icon
36
Procter & Gamble
PG
$340B
$3.85M 0.71%
27,548
-671
-2% -$95.1K
IJJ icon
37
iShares S&P Mid-Cap 400 Value ETF
IJJ
$8.95B
$3.62M 0.66%
35,176
+7,965
+29% +$837K
IWS icon
38
iShares Russell Mid-Cap Value ETF
IWS
$15.8B
$3.62M 0.66%
31,946
+6,604
+26% +$764K
AMZN icon
39
Amazon
AMZN
$3T
$3.38M 0.62%
20,580
-600
-3% -$103K
USMV icon
40
iShares MSCI USA Min Vol Factor ETF
USMV
$23.8B
$3.35M 0.61%
+45,582
New +$3.47M
XOM icon
41
ExxonMobil
XOM
$634B
$3.17M 0.58%
53,978
+3
+0% +$171
MRK icon
42
Merck
MRK
$318B
$3.13M 0.57%
41,685
-2,062
-5% -$157K
IWN icon
43
iShares Russell 2000 Value ETF
IWN
$14.6B
$3.13M 0.57%
19,524
-1,184
-6% -$190K
JNJ icon
44
Johnson & Johnson
JNJ
$608B
$3.09M 0.57%
19,152
-1,000
-5% -$171K
ACWI icon
45
iShares MSCI ACWI ETF
ACWI
$33.2B
$3.07M 0.56%
30,760
+100
+0.3% +$10.3K
HD icon
46
Home Depot
HD
$342B
$2.98M 0.55%
9,074
-900
-9% -$296K
GLD icon
47
SPDR Gold Trust
GLD
$132B
$2.77M 0.51%
16,875
-35
-0.2% -$5.86K
PFE icon
48
Pfizer
PFE
$142B
$2.75M 0.51%
64,045
+3
+0% +$133
XSVM icon
49
Invesco S&P SmallCap Value with Momentum ETF
XSVM
$682M
$2.7M 0.5%
53,582
-23,036
-30% -$1.14M
IJS icon
50
iShares S&P Small-Cap 600 Value ETF
IJS
$8.33B
$2.61M 0.48%
25,953
-1,865
-7% -$188K

Similar funds

Crescent Capital Consulting's Q3 2021 Portfolio in Review

As of Q3 2021, Crescent Capital Consulting held 625 positions worth $546M, up 2.1% from $534M the previous quarter. Its ten largest holdings account for 39% of the portfolio.

Crescent Capital Consulting deployed $36.1M of net new capital in Q3 2021, opening 124 new positions and adding to 56 existing holdings. Its largest new stake was iShares MSCI USA Min Vol Factor ETF: 45,582 shares worth $3.35M.

By sector, the portfolio is most concentrated in Technology at 4.9% of assets, down from 5.1% a quarter earlier, followed by Healthcare and Consumer Staples.

On the sell side, the largest reduction was State Street SPDR Portfolio Mortgage Backed Bond ETF, an estimated $12.3M trimmed.

  • Crescent Capital Consulting's largest Q3 2021 buy was iShares MSCI USA Min Vol Factor ETF: 45,582 shares worth $3.35M.
  • Crescent Capital Consulting added most to iShares Russell 1000 Growth ETF in Q3 2021, an estimated $18.6M increase.
  • Crescent Capital Consulting's biggest Q3 2021 reduction was State Street SPDR Portfolio Mortgage Backed Bond ETF, cutting an estimated $12.3M.
  • Crescent Capital Consulting fully exited Luminex Corp in Q3 2021, selling an estimated $660K.
  • Crescent Capital Consulting's ten largest holdings make up 39% of its $546M portfolio in Q3 2021.
  • Crescent Capital Consulting opened 124 new positions and closed 32 in Q3 2021.
  • Crescent Capital Consulting's portfolio value rose 2.1% quarter-over-quarter to $546M.

Based on Crescent Capital Consulting's 13F filing for Q3 2021, filed 12 Oct 2021.